Adaptive has partnered with scientists at leading institutions and biopharmaceutical companies around the world. Together we are working at the forefront of immune-based discoveries and validated diagnostics to advance science and improve patient care worldwide.
Member of the Translational Research Program Benaroya Research Institute
Can we identify T-cell receptor signatures that track autoimmune disease type 1 diabetes?
Associate Professor of Molecular Microbiology & Immunology Saint Louis University, School of Medicine
Can we identify antigen specific TCRs and track the relative TCR frequencies during an immune response to infections or vaccines?
Post-Doctoral Fellow, Department of Medicine, Allergy and Immunology Division, Northwestern University
What is the mechanism of B-cell activation in inflammation associated with chronic rhinosinusitis (CRS)?
Associate Professor in Pathology and Laboratory Medicine Parker Institute for Cancer Immunotherapy Center for Cellular Immunotherapies Perelman School of Medicine University of Pennsylvania
Can we use genomic information to create better vaccines against cancer?
Research Fellow Massachusetts General Hospital, Harvard Medical School
Can we identify and characterize the B-cell population that infiltrates cardiac tissue after transplant?
Fowler McCormick Professor of Surgery Director of Kidney and Pancreas Transplantation The Comprehensive Transplant Center Northwestern University Feinberg School of Medicine
Can recipients of kidney plus HSC/FC transplant establish graft tolerance while recovering immunocompetence?
Assistant Professor of Medicine Perelman School of Medicine, University of Pennsylvania
What is the role of T-cell trafficking in the development of graft versus host disease (GVHD) after hematopoietic stem-cell transplantation (HSCT)?
Associate Professor in Neurosurgery David Geffen School of Medicine at UCLA
Can immunosequencing help predict clinical responses after dendritic cell vaccination in patients with glioblastoma?
Professor, Melanoma Medical Oncology, University of Texas MD Anderson Cancer Center; Member of the Clinical Research Division Fred Hutchinson Cancer Research Center
How do tumor-specific T-cell populations change after personalized therapy to melanoma?
Research Fellow in Immunology at the Mass General Hospital Associate Pathologist at the Center for Advanced Molecular Diagnostics and the Brigham and Women’s Hospital
What can we learn about the pathogenesis of IgG4-related disease, a poorly understood immune-mediated disorder of possible autoimmune etiology?